ROCHESTER, N.Y., Jan. 11, 2016 (GLOBE NEWSWIRE) -- Transcat, Inc. (NASDAQ:TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration and compliance services and distributor of professional grade handheld test, measurement and control instrumentation, announced today that it will release its third quarter fiscal year 2016 results before the opening of financial markets on Monday, January 25, 2016.
The Company will host a conference call and webcast to review the financial and operating results for the period and discuss its corporate strategy and outlook. A question-and-answer session will follow.
Third Quarter Fiscal Year 2016 Conference Call
Monday, January 25, 2016
11:00 a.m. Eastern Time
Phone: (201) 689-8471
Internet Webcast: www.transcat.com/investor-relations
A telephonic replay will be available from 2:00 p.m. ET on the day of the teleconference until Monday, February 1, 2016. To listen to the archived call, dial (858) 384-5517 and enter conference ID number 13627606, or access the webcast replay via the Company website at www.transcat.com/investor-relations, where a transcript will be posted once available.
ABOUT TRANSCAT
Transcat, Inc. is a leading provider of accredited calibration and compliance services, including analytical instrument qualifications, equipment and process validation. The Company is focused on providing best-in-class calibration analytics to highly regulated industries, including life science, aerospace, pharmaceuticals, medical device manufacturing and biotechnology. Transcat performs over 250,000 specialized technical services annually through a variety of delivery options, including permanent and periodic on-site services, mobile calibration services and in-house services (often accompanied by pick-up and delivery). The in-house services are offered through 20 Calibration Service Centers strategically located across the United States, Puerto Rico and Canada. The breadth and depth of measurement parameters addressed by Transcat’s ISO/IEC 17025 scopes of accreditation are believed to be the best in the industry. Transcat also answers the call with cGMP and GLP compliant services.
In addition, Transcat operates as a leading distributor of professional grade handheld test, measurement and control instrumentation, marketing more than 100,000 premier and proprietary brand instruments to approximately 22,000 customers.
Transcat’s growth strategy is to leverage its service capabilities, strong brand and leading distribution platform to drive organic sales growth and to expand its addressable calibration market through acquisitions and capability investments to further realize the inherent leverage of its business model.
More information about Transcat can be found on its website at: Transcat.com.
For more information contact: John J. Zimmer, Chief Financial Officer Phone: (585) 352-7777 Email: [email protected] Deborah K. Pawlowski, Investor Relations Phone: (716) 843-3908 Email: [email protected]


UPS and Teamsters Reach Agreement to Limit Driver Severance Program
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Britain Courts Anthropic Amid US Defense Department Dispute
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Samsung Electronics Eyes Record Q1 Profit Amid AI-Driven Chip Boom
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation 



